Inflamación y Daño Vascular en la Enfermedad Renal Crónica, Diálisis y Trasplante Renal. Fisiopatología renal

Vega, A; Ruiz, C; Abad, S; Quiroga, B; Velazquez, K; Yuste, C; Aragoncillo, I; Gomez, JML.

Body composition affects the response to erythropoiesis-stimulating agents in patients with chronic kidney disease in dialysis

RENAL FAILURE. 2014; 36(7): 1073-1077 Nº de citas: 17 [doi:10.3109/0886022X.2014.917937]

Vega, A; de Vinuesa, SG; Goicoechea, M; Verdalles, U; Martinez-Pueyo, ML; Chacon, A; Quiroga, B; Luno, J.

Evaluation of methods based on creatinine and cystatin C to estimate glomerular filtration rate in chronic kidney disease

INTERNATIONAL UROLOGY AND NEPHROLOGY. 2014; 46(6): 1161-1167 Nº de citas: 12 [doi:10.1007/s11255-013-0607-8]

Bouza, E; Rojas, L; Guembe, M; Marin, M; Anaya, F; Luno, J; Lopez, JM; Munoz, P.

Predictive value of superficial cultures to anticipate tunneled hemodialysis catheter-related bloodstream infection

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2014; 78(3): 316-319 Nº de citas: 22 [doi:10.1016/j.diagmicrobio.2013.12.008]

de Jose, AP; Verdalles-Guzman, U; Abad, S; Vega, A; Reque, J; Panizo, N; Rincon, A; Yuste, C; Arroyo, D; Lopez-Gomez, JM.

Metabolic syndrome is associated with cardiovascular events in haemodialysis

NEFROLOGIA. 2014; 34(1): 69-75 Nº de citas: 13 [doi:10.3265/Nefrologia.pre2013.Oct.12092]

Arroyo, D; Panizo, N; Abad, S; Vega, A; Perez-de Jose, A; Lopez-Gomez, JM.

The effect of replacing aluminium hydroxide with calcium acetate/magnesium carbonate on serum phosphorus control in haemodialysis patients

NEFROLOGIA. 2014; 34(2): 199-204 Nº de citas: 2 [doi:10.3265/Nefrologia.pre2013.Nov.12145]

Quiroga, B; Villaverde, M; Vega, A; Abad, S; Reque, J; Lopez-Gomez, JM.

Procalcitonin as an early predictor of acute infection in hemodialysis patients

NEFROLOGIA. 2014; 34(3): 341-346 Nº de citas: 9 [doi:10.3265/Nefrologia.pre2014.Mar.12313]

Gorostidi, M; Santamaria, R; Alcazar, R; Fernandez-Fresnedo, G; Galceran, JM; Goicoechea, M; Oliveras, A; Portoles, J; Rubio, E; Segura, J; Aranda, P; de Francisco, ALM; del Pino, MD; Fernandez-Vega, F; Gorriz, JL; Luno, J; Marin, R; Martinez, I; Martinez-Castelao, A; Orte, LM; Quereda, C; Rodriguez-Perez, JC; Rodriguez, M; Ruilope, LM.

Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease

NEFROLOGIA. 2014; 34(3): 302-316 Nº de citas: 45 [doi:10.3265/Nefrologia.pre2014.Feb.12464]

Runkle, I; Villabona, C; Navarro, A; Pose, A; Formiga, F; Tejedor, A; Poch, E.

Treatment of hyponatremia induced by the syndrome of inappropriate antidiuretic hormone secretion: a multidisciplinary algorithm

NEFROLOGIA. 2014; 34(4): 439-450 Nº de citas: 20 [doi:10.3265/Nefrologia.pre2014.Apr.12220]

Vega, A; Quiroga, B; Abad, S; Ruiz, C; Lopez-Gomez, JM.

Study on overhydration in dialysis patients and its association with inflammation

NEFROLOGIA. 2014; 34(5): 579-583 Nº de citas: 19 [doi:10.3265/Nefrologia.pre2014.Jun.12422]

Vega, A; Abad, S; Verdalles, U; Aragoncillo, I; Velazquez, K; Quiroga, B; Escudero, V; Lopez-Gomez, JM.

Dose equivalence between continuous erythropoietin receptor activator (CERA), Darbepoetin and Epoetin in patients with advanced chronic kidney disease

Hippokratia. 2014; 18(4): 315-318 Nº de citas: 14

Macias, N; Goicoechea, M; de Vinuesa, MSG; Verdalles, U; Luno, J.

Urate Reduction and Renal Preservation: What Is the Evidence?

Current Rheumatology Reports. 2013; 15(12): Nº de citas: 4 [doi:10.1007/s11926-013-0386-3]

Fernandez-Juarez, G; Luno, J; Barrio, V; de Vinuesa, SG; Praga, M; Goicoechea, M; Lahera, V; Casas, L; Oliva, J.

25 (OH) Vitamin D Levels and Renal Disease Progression in Patients with Type 2 Diabetic Nephropathy and Blockade of the Renin-Angiotensin System

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2013; 8(11): 1870-1876 Nº de citas: 89 [doi:10.2215/CJN.00910113]

Rojas, L; Munoz, P; Kestler, M; Arroyo, D; Guembe, M; Rodriguez-Creixems, M; Verde, E; Bouza, E.

Bloodstream infections in patients with kidney disease: risk factors for poor outcome and mortality

JOURNAL OF HOSPITAL INFECTION. 2013; 85(3): 196-205 Nº de citas: 34 [doi:10.1016/j.jhin.2013.07.009]

Yuste, C; De Vinuesa, SG; Goicoechea, M; Barraca, D; Panizo, N; Quiroga, B; Luno, J.

Vitamin D deficiency in a Spanish cohort of patients with chronic kidney disease

MEDICINA CLINICA. 2013; 141(8): 338-342 Nº de citas: 5 [doi:10.1016/j.medcli.2012.07.026]

Fermoselle, C; Garcia-Arumi, E; Puig-Vilanova, E; Andreu, AL; Urtreger, AJ; Joffe, EDBD; Tejedor, A; Puente-Maestu, L; Barreiro, E.

Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice

EXP PHYSIOL. 2013; 98(9): 1349-1365 Nº de citas: 62 [doi:10.1113/expphysiol.2013.072496]

Panizo, N; Rivera, F; Lopez-Gomez, JM.

Decreasing incidence of AA amyloidosis in Spain

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2013; 43(8): 767-773 Nº de citas: 16 [doi:10.1111/eci.12097]

Escudero-Vilaplana, V; Martinez-Nieto, C; Lopez-Gomez, JM; Vega-Martinez, A; Bellon-Cano, JM; Sanjurjo-Saez, M.

Erythropoiesis-stimulating agents in anaemia due to chronic kidney disease: a cost-minimization analysis

International Journal of Clinical Pharmacy. 2013; 35(3): 463-468 Nº de citas: 6 [doi:10.1007/s11096-013-9774-z]

Puente-Maestu, L; Lazaro, A; Humanes, B.

Metabolic derangements in COPD muscle dysfunction

J APPL PHYSIOL. 2013; 114(9): 1282-1290 Nº de citas: 25 [doi:10.1152/japplphysiol.00815.2012]